Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario da Coruña (226)

2024

  1. 18F-FDG-PET/CT Scan for Detection of Large Vessel Involvement in Giant Cell Arteritis: Arteser Spanish Registry

    Journal of Clinical Medicine, Vol. 13, Núm. 20

  2. An exploratory analysis of associations of genetic variation with the efficacy of tocilizumab in severe COVID-19 patients. A pharmacogenetic study based on next-generation sequencing

    Frontiers in Pharmacology, Vol. 15

  3. Anti-Inflammatory Activity of APPA (Apocynin and Paeonol) in Human Articular Chondrocytes

    Pharmaceuticals, Vol. 17, Núm. 1

  4. Can gait patterns be explained by joint structure in people with and without radiographic knee osteoarthritis? Data from the IMI-APPROACH cohort

    Skeletal Radiology, Vol. 53, Núm. 11, pp. 2409-2416

  5. Core items to be included in a definition of moderate psoriatic arthritis: literature review and expert opinion

    Rheumatology International, Vol. 44, Núm. 11, pp. 2327-2336

  6. Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis

    European Journal of Internal Medicine, Vol. 129, pp. 78-86

  7. Higher Synovial Immunohistochemistry Reactivity of IL-17A, Dkk1, and TGF-β1 in Patients with Early Psoriatic Arthritis and Rheumatoid Arthritis Could Predict the Use of Biologics

    Biomedicines, Vol. 12, Núm. 4

  8. Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register

    RMD open, Vol. 10, Núm. 1

  9. Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry

    Annals of the Rheumatic Diseases, Vol. 83, Núm. 9, pp. 1189-1199

  10. Metabolic syndrome is not associated with erosive hand osteoarthritis: a cross-sectional study using data from the PROCOAC cohort

    Scientific Reports, Vol. 14, Núm. 1

  11. Mitochondrial Role on Cellular Apoptosis, Autophagy, and Senescence during Osteoarthritis Pathogenesis

    Cells, Vol. 13, Núm. 11

  12. Mitonuclear epistasis involving TP63 and haplogroup Uk: Risk of rapid progression of knee OA in patients from the OAI

    Osteoarthritis and Cartilage, Vol. 32, Núm. 5, pp. 526-534

  13. Nutritional Epigenomics: Bioactive Dietary Compounds in the Epigenetic Regulation of Osteoarthritis

    Pharmaceuticals, Vol. 17, Núm. 9

  14. OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments

    Seminars in Arthritis and Rheumatism, Vol. 65

  15. Real-World Effectiveness and Safety of SDZ ETN, an Etanercept Biosimilar, in Patients with Rheumatic Diseases: Final Results from Multi-Country COMPACT Study

    Advances in Therapy, Vol. 41, Núm. 1, pp. 315-330

  16. SER recommendations on treatment of refractory Behçet's syndrome

    Reumatologia Clinica, Vol. 20, Núm. 4, pp. 204-217

  17. SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

    Lupus Science and Medicine, Vol. 11, Núm. 1

  18. Seven-chain adaptive immune receptor repertoire analysis in rheumatoid arthritis reveals novel features associated with disease and clinically relevant phenotypes

    Genome Biology, Vol. 25, Núm. 1

  19. Severity and progression of structural hand OA is not associated with progression of structural knee OA: The IMI-APPROACH cohort

    Osteoarthritis and Cartilage Open, Vol. 6, Núm. 3

  20. Similarities and differences between systemic juvenile idiopathic arthritis and adult-onset Still’s disease: a multicenter Spanish study

    Rheumatology International